Asset Management Corp Clearside Biomedical, Inc. Transaction History
Asset Management Corp
- $146 Million
- Q1 2023
A detailed history of Asset Management Corp transactions in Clearside Biomedical, Inc. stock. As of the latest transaction made, Asset Management Corp holds 14,000 shares of CLSD stock, worth $17,780. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,000Holding current value
$17,780% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding CLSD
# of Institutions
56Shares Held
15.1MCall Options Held
22.7KPut Options Held
200-
Armistice Capital, LLC New York, NY3.96MShares$5.02 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.49MShares$3.16 Million0.0% of portfolio
-
Act Capital Management, LLC Wayne, PA2.2MShares$2.79 Million3.43% of portfolio
-
Carmignac Gestion Paris, I02.13MShares$2.71 Million0.05% of portfolio
-
Black Rock Inc. New York, NY758KShares$962,9470.0% of portfolio
About Clearside Biomedical, Inc.
- Ticker CLSD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,190,700
- Market Cap $76.4M
- Description
- Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...